vs
Lakeside Holding Ltd（LSH）与Spero Therapeutics, Inc.（SPRO）财务数据对比。点击上方公司名可切换其他公司
Spero Therapeutics, Inc.的季度营收约是Lakeside Holding Ltd的1.8倍（$12.6M vs $7.0M），Spero Therapeutics, Inc.净利率更高（250.7% vs -22.6%，领先273.3%），Spero Therapeutics, Inc.同比增速更快（24080.8% vs 95.0%）
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
LSH vs SPRO — 直观对比
营收规模更大
SPRO
是对方的1.8倍
$7.0M
营收增速更快
SPRO
高出23985.7%
95.0%
净利率更高
SPRO
高出273.3%
-22.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $12.6M |
| 净利润 | $-1.6M | $31.5M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -21.3% | — |
| 净利率 | -22.6% | 250.7% |
| 营收同比 | 95.0% | 24080.8% |
| 净利润同比 | 18.7% | 250.9% |
| 每股收益（稀释后） | $-0.08 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSHSPRO
| Q4 25 | $7.0M | $12.6M | ||
| Q3 25 | $6.1M | $0 | ||
| Q2 25 | $6.3M | $0 | ||
| Q1 25 | $3.8M | $12.0K | ||
| Q4 24 | $3.6M | $52.0K | ||
| Q3 24 | $4.1M | $65.0K | ||
| Q2 24 | — | $114.0K | ||
| Q1 24 | — | $140.0K |
净利润LSHSPRO
| Q4 25 | $-1.6M | $31.5M | ||
| Q3 25 | $-1.4M | $-7.4M | ||
| Q2 25 | $-893.1K | $-1.7M | ||
| Q1 25 | $-1.1M | $-13.9M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.3M | $-17.1M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-12.7M |
毛利率LSHSPRO
| Q4 25 | 27.2% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率LSHSPRO
| Q4 25 | -21.3% | — | ||
| Q3 25 | -20.8% | — | ||
| Q2 25 | -8.9% | — | ||
| Q1 25 | -28.2% | -122758.3% | ||
| Q4 24 | -55.6% | — | ||
| Q3 24 | -32.5% | -28604.6% | ||
| Q2 24 | — | -16720.2% | ||
| Q1 24 | — | -9987.1% |
净利率LSHSPRO
| Q4 25 | -22.6% | 250.7% | ||
| Q3 25 | -22.2% | — | ||
| Q2 25 | -14.2% | — | ||
| Q1 25 | -28.2% | -115550.0% | ||
| Q4 24 | -54.1% | — | ||
| Q3 24 | -32.7% | -26380.0% | ||
| Q2 24 | — | -15668.4% | ||
| Q1 24 | — | -9049.3% |
每股收益（稀释后）LSHSPRO
| Q4 25 | $-0.08 | $0.56 | ||
| Q3 25 | $-0.09 | $-0.13 | ||
| Q2 25 | $-0.11 | $-0.03 | ||
| Q1 25 | $-0.14 | $-0.25 | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.18 | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | $40.3M |
| 总债务越低越好 | $2.4M | — |
| 股东权益账面价值 | $12.2M | $59.0M |
| 总资产 | $24.3M | $68.9M |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资LSHSPRO
| Q4 25 | $1.6M | $40.3M | ||
| Q3 25 | $4.5M | $48.6M | ||
| Q2 25 | $5.0M | $31.2M | ||
| Q1 25 | $1.5M | $48.9M | ||
| Q4 24 | $1.1M | $52.9M | ||
| Q3 24 | $2.7M | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
总债务LSHSPRO
| Q4 25 | $2.4M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $774.2K | — | ||
| Q4 24 | $784.8K | — | ||
| Q3 24 | $589.9K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LSHSPRO
| Q4 25 | $12.2M | $59.0M | ||
| Q3 25 | $7.0M | $26.5M | ||
| Q2 25 | $2.8M | $32.8M | ||
| Q1 25 | $749.8K | $33.8M | ||
| Q4 24 | $1.6M | $46.1M | ||
| Q3 24 | $3.6M | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
总资产LSHSPRO
| Q4 25 | $24.3M | $68.9M | ||
| Q3 25 | $18.6M | $54.2M | ||
| Q2 25 | $14.4M | $62.1M | ||
| Q1 25 | $9.9M | $77.7M | ||
| Q4 24 | $9.8M | $110.5M | ||
| Q3 24 | $10.8M | $135.2M | ||
| Q2 24 | — | $149.9M | ||
| Q1 24 | — | $167.7M |
负债/权益比LSHSPRO
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-453.5K | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LSHSPRO
| Q4 25 | $-453.5K | $-8.4M | ||
| Q3 25 | $-4.0M | $17.4M | ||
| Q2 25 | $-483.7K | $-17.7M | ||
| Q1 25 | $-238.3K | $-4.0M | ||
| Q4 24 | $-530.2K | $-23.4M | ||
| Q3 24 | $-1.4M | $12.8M | ||
| Q2 24 | — | $-18.7M | ||
| Q1 24 | — | $5.9M |
自由现金流LSHSPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-497.4K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-560.5K | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率LSHSPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -7.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.6% | — | ||
| Q3 24 | -34.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度LSHSPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率LSHSPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
SPRO
暂无分部数据
